Literature DB >> 3112299

Pathways in the formation of human plasma high density lipoprotein subpopulations containing apolipoprotein A-I without apolipoprotein A-II.

A V Nichols, E L Gong, P J Blanche, T M Forte, V G Shore.   

Abstract

The lecithin:cholesterol acyltransferase (LCAT)-induced transformation of two discrete species of model complexes that differ in number of apolipoprotein A-I (apoA-I) molecules per particle was investigated. One complex species (designated 3A-I(UC)-complexes) contained 3 apoA-I per particle, was discoidal (13.5 X 4.4 nm), and had a molar composition of 22:78:1 (unesterified cholesterol (UC):egg yolk phosphatidylcholine (egg yolk PC):apoA-I). The other complex species (designated 2A-I(UC)complexes) containing 2 apoA-I per particle was also discoidal (8.4 X 4.1 nm) and had a molar composition of 6:40:1. Transformation of 3A-I(UC)complexes by partially purified LCAT yielded a product (24 hr, 37 degrees C) with a cholesteryl ester (CE) core, 3 apoA-I, and a mean diameter of 9.2 nm. The 2A-I(UC)complexes were only partially transformed to a core-containing product (24 hr, 37 degrees C) which also had 3 apoA-I; this product, however, was smaller (diameter of 8.5 nm) than the product from 3A-I(UC)complexes. Transformation of 3A-I(UC)complexes appeared to result from build-up of core CE directly within the precursor complex. Transformation of 2A-I(UC)complexes, however, followed a stepwise pathway to the product with 3 apoA-I, apparently involving fusion of transforming precursors and release of one apoA-I from the fusion product. In the presence of low density lipoprotein (LDL), used as a source of additional cholesterol, conversion of 2A-I(UC)complexes to the product with 3 apoA-I was more extensive. The transformation product of 3A-I(UC)complexes in the presence of LDL also had 3 apoA-I but was considerably smaller in size (8.6 vs. 9.2 nm, diameter) and had a twofold lower molar content of PC compared with the product formed without LDL. LDL appeared to act both as a donor of UC and an acceptor of PC. Transformation products with 3 apoA-I obtained under the various experimental conditions in the present studies appear to be constrained in core CE content (between 13 to 22 CE per apoA-I; range of 9 CE molecules) but relatively flexible in content of surface PC molecules they can accommodate (between 24 to 49 PC per apoA-I; range of 25 PC molecules). The properties of the core-containing products with 3 apoA-I compare closely with those of the major subpopulation of human plasma HDL in the size range of 8.2-8.8 nm that contains the molecular weight equivalent of 3 apoA-I molecules.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3112299

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Assessment of the validity of the double superhelix model for reconstituted high density lipoproteins: a combined computational-experimental approach.

Authors:  Martin K Jones; Lei Zhang; Andrea Catte; Ling Li; Michael N Oda; Gang Ren; Jere P Segrest
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

2.  Conformational analysis of apolipoprotein E3/E4 heteromerization.

Authors:  Kai-Han Tu; Devan Abhari; Vasanthy Narayanaswami
Journal:  FEBS J       Date:  2019-03-13       Impact factor: 5.542

3.  Structure of apolipoprotein A-I N terminus on nascent high density lipoproteins.

Authors:  Jens O Lagerstedt; Giorgio Cavigiolio; Madhu S Budamagunta; Ioanna Pagani; John C Voss; Michael N Oda
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

4.  The role of apolipoprotein AI domains in lipid binding.

Authors:  W S Davidson; T Hazlett; W W Mantulin; A Jonas
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

5.  Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.

Authors:  X Jiang; O L Francone; C Bruce; R Milne; J Mar; A Walsh; J L Breslow; A R Tall
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

6.  Conservation of apolipoprotein A-I's central domain structural elements upon lipid association on different high-density lipoprotein subclasses.

Authors:  Michael N Oda; Madhu S Budamagunta; Ethan G Geier; Sajiv H Chandradas; Baohai Shao; Jay W Heinecke; John C Voss; Giorgio Cavigiolio
Journal:  Biochemistry       Date:  2013-09-17       Impact factor: 3.162

7.  Low-density lipoprotein receptor-related protein 1 is a novel modulator of radial glia stem cell proliferation, survival, and differentiation.

Authors:  Dina Safina; Frederik Schlitt; Ramona Romeo; Thorsten Pflanzner; Claus U Pietrzik; Vasanthy Narayanaswami; Frank Edenhofer; Andreas Faissner
Journal:  Glia       Date:  2016-06-03       Impact factor: 7.452

8.  The secondary structure of apolipoprotein A-I on 9.6-nm reconstituted high-density lipoprotein determined by EPR spectroscopy.

Authors:  Michael N Oda; Madhu S Budamagunta; Mark S Borja; Jitka Petrlova; John C Voss; Jens O Lagerstedt
Journal:  FEBS J       Date:  2013-06-10       Impact factor: 5.542

Review 9.  Reconfiguring Nature's Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents.

Authors:  Skylar T Chuang; Siobanth Cruz; Vasanthy Narayanaswami
Journal:  Nanomaterials (Basel)       Date:  2020-05-08       Impact factor: 5.076

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.